James Peyer, Director, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 15,000 shares at $4.31 ($64K) on 2022-01-27, disclosed to the SEC on 2022-01-31.
Open-market purchase of $64k SNSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.31 | 6,100 | $26K | 41.2% |
| 2 | $4.22 | 8,900 | $38K | 58.8% |
| Total | $4.26 avg | 15,000 | $64K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |